论文部分内容阅读
目的观察注射用头孢哌酮钠/舒巴坦钠治疗下呼吸道感染的有效性和安全性。方法80例下呼吸道感染患者随机分为治疗组和对照组,治疗组静脉滴注头孢哌酮钠/舒巴坦钠2g,每12小时1次,疗程10～14天,对照组静滴注射用头孢他啶2g,每12小时1次,疗程10～14天。结果治疗组和对照组治疗下呼吸道感染的有效率分别为96%和95.5%,细菌清除率分别为89.8%和87.8%,不良反应发生率为6.8%和8.8%。结论头孢哌酮钠/舒巴坦钠治疗下呼吸道感染疗效高,安全性好。
Objective To observe the efficacy and safety of cefoperazone sodium / sulbactam sodium for the treatment of lower respiratory tract infection. Methods Eighty patients with lower respiratory tract infection were randomly divided into treatment group and control group. The treatment group received cefoperazone sodium / sulbactam sodium 2g intravenously once every 12 hours for 10 to 14 days. In the control group, ceftazidime 2g, Every 12 hours 1, treatment of 10 to 14 days. Results The effective rates of treatment of lower respiratory tract infection in the treatment group and control group were 96% and 95.5% respectively, the bacterial clearance rate was 89.8% and 87.8% respectively, and the incidence of adverse reactions was 6.8% and 8.8%. Conclusion Cefoperazone sodium / sulbactam sodium treatment of lower respiratory tract infection with high efficacy, good safety.